Xi Liu
Fondatore presso BEIJING STRONG BIOTECHNOLOGIES,INC.
Patrimonio netto: 159 M $ in data 31/05/2024
Profilo
Xi Liu founded Beijing Strong Biotechnologies, Inc. in 2001, where he is working as General Manager & Director from 2011.
Dr. Liu also currently works at Fuzhou Maixin Biotech Co., Ltd., as Director from 2020.
Dr. Liu received his graduate degree in 1982 from Harbin Engineering University and doctorate degree in 1988 from Institute of Automation Chinese Academy of Sciences.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
30/06/2023 | 50 260 257 ( 19.76% ) | 120 M $ | 31/05/2024 | |
30/06/2023 | 16 753 419 ( 5.01% ) | 40 M $ | 31/05/2024 |
Posizioni attive di Xi Liu
Società | Posizione | Inizio |
---|---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Fondatore | 29/03/2001 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Direttore/Membro del Consiglio | 30/09/2020 |
Formazione di Xi Liu
Harbin Engineering University | Graduate Degree |
Institute of Automation Chinese Academy of Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
Aziende private | 1 |
---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Borsa valori
- Insiders
- Xi Liu